Nirrin Technologies
PrivateLast Round
Seed Round
Sep 23, 2025
Total Funding Raised
$6.82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nirrin Technologies operates in Healthcare & Life Sciences and is based in Billerica, Massachusetts. Its latest recorded funding round was a Grant round in September 2024.
Nirrin Technologies is a biotechnology company that develops analytical instruments with proprietary laser spectroscopy technology for real-time bioprocess monitoring and protein quantitation.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nirrin Technologies Comparables
Compare Nirrin Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IRUBIS | 88% | |
| Endress+Hauser | 76% | |
| CLADE | 76% |
For institutional investors. Book with your work email.
Nirrin Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 23, 2025 | ||||
| Grant | Sep 4, 2024 | ||||
| Series A | Feb 1, 2024 | ||||
| VC Round | Sep 23, 2021 |
For institutional investors. Book with your work email.
Nirrin Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gamma Biosciences | VC Round |
| NIH RADx | Grant |
| Anzu Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 7, 35% of headcount.
- Aug 21, 2026
Monthly visitors grew 33% MoM, from 1.5K to 2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 15, 2026
Nirrin showcases its Tunable Laser Near-Infrared platform and analytical workflows at BPI Conference and Exhibition in Massachusetts on Sep 22-25 '26.
For institutional investors. Book with your work email.
Nirrin Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nirrin Technologies's valuation, stock price, and market status.
Is Nirrin Technologies a public or private company?
Nirrin Technologies is a private company.
What is the current stock price of Nirrin Technologies?
Nirrin Technologies is a private company, so its shares have no public market price. Caplight tracks Nirrin Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nirrin Technologies worth (valuation)?
Valuation information for Nirrin Technologies is not publicly available.
Can I buy Nirrin Technologies stock?
Nirrin Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nirrin Technologies's last funding round?
Nirrin Technologies's most recent funding round was Seed Round on September 23, 2025.
Who are the main investors in Nirrin Technologies?
Key investors in Nirrin Technologies include Gamma Biosciences, NIH RADx, Anzu Partners.
Will Nirrin Technologies IPO soon?
No public IPO plans have been announced for Nirrin Technologies.
How can I track Nirrin Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Nirrin Technologies's shares on secondary markets.